Trial reportJournal of neuroengineering and rehabilitation2026
Visual feedback increases expiratory muscle training effort in Parkinson's disease: a randomised crossover trial.
Trial report in Journal of neuroengineering and rehabilitation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06942533 (The Effect of Visual Feedback From the SpiroGym Mobile Application on Expiratory Muscle Strength Training Performance in Patients With Parkinson's Disease), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
The Effect of Visual Feedback From the SpiroGym Mobile Application on Expiratory Muscle Strength Training Performance in Patients With Parkinson's Disease
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundDisorders of airway protection, including impaired cough and swallowing, are clinically important complications of Parkinson's disease. Expiratory muscle strength training (EMST) is an established non-pharmacological intervention targeting these deficits. The aim of this study was to evaluate the acute effect of visual feedback provided by the SpiroGym mHealth app on expiratory muscle activation during EMST in people with Parkinson's disease.
methodsWe conducted a single-center, randomised, two-period crossover trial in people with Parkinson's disease. Participants performed EMST under two conditions, in randomised order: conventional EMST without visual feedback and EMST with real-time visual feedback provided by the SpiroGym app. Expiratory muscle activation was measured using surface electromyography of the abdominal muscles. The primary outcome was the within-participant difference in mean peak normalised internal oblique activity between conditions. Secondary outcomes included external oblique and rectus abdominis activity, associations with neuropsychiatric symptoms, and participant-reported usability ratings.
resultsTwenty participants were randomised, and 19 completed the study and were included in the final analysis. No study-related adverse events occurred. Visual feedback significantly increased mean peak normalised internal oblique activity compared with no feedback (118.2 ± 36.4% vs. 90.5 ± 23.0% of reference voluntary contraction; p < 0.001; Cohen d = 0.95). Without feedback, internal oblique activation significantly declined from 100.1 ± 22.2% in the first set to 84.4 ± 25.5% in the fifth set, whereas it remained stable with feedback (120.3 ± 29.4% to 119.9 ± 40.6%). External oblique activation was also significantly higher with feedback (122.2 ± 38.1% vs. 100.9 ± 32.4%; p = 0.002; Cohen d = 0.66), while rectus abdominis activation did not differ significantly between conditions (105.2 ± 41.3% vs. 90.2 ± 36.1%; p = 0.06; Cohen d = 0.43). No significant associations between feedback responsiveness and depression, apathy, or anxiety were detected. Participants rated the visual feedback as easy to understand and helpful for EMST performance.
conclusionsReal-time visual feedback delivered by the SpiroGym app acutely increased and stabilized expiratory muscle activation during EMST in people with Parkinson's disease. Trial registration ClinicalTrials.gov NCT06942533, 1 May 2025.
Indexed as
Identifiers
42881452What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.